Pathology at Johns Hopkins

The Department of Pathology at Johns Hopkins is preeminent nationally and globally in the study and treatment of human disease and in professional training in all areas of pathology and laboratory science. Currently, there are over 1400 people in the department, which includes approximately 120 full-time faculty, 36 residents, 45 graduate students, over 100 fellows, and 1000 staff members.

Grand Rounds



Pathobiology Thesis Seminar

No upcoming seminar scheduled.

Learn more about our Pathobiology Program »



Department Blog

Loading Blog Feeds

All Pathology blogs >>

What's New?

Čiháková Lab in European Journal of Immunology

December 6, 2016

European Journal of Immunology
Below is the description of the picture from the journal itself: Back cover features an H&E stained biopsy section from a patient with eosinophilic myocarditis. Countless heart-infiltrating eosinophils with bright pink granules and bi-lobed nuclei are visible between large, striated cardiomyocytes. In addition, T cells and macrophages are infiltrating the heart. This image relates to the article by Diny et al. (pp. 2749-2760), in which the authors analyze the pathway required for eosinophil trafficking to the heart by examining heart biopsies from myocarditis patients and a murine myocarditis model. IL-4 and IL-13 induce production of eotaxins CCL11 and CCL24 by cardiac fibroblasts and macrophages. In response to eotaxins, eosinophils migrate to the heart via the receptor CCR3.

Read full article.



Dr. Tim Amukele in Baltimore Style Magazine

November 30, 2016

Dr. Tim Amukele
Baltimore Style Magazine features Dr. Tim Amukele and how his blood-transporting drones are helping underdeveloped countries. Read the article.



As Featured in the American Journal of Pathology

November 28, 2016

Dr. Mario Caturegli, Dr. Ben Larman, and Dr. Tatianna Larman recently published an article in the American Journal of Pathology that was selected as one of the two monthly editor's choices and featured on the front cover.

The article reports the first pathological examination of the pituitary gland in a cancer patient who was treated with a checkpoint inhibitor and developed hypophysitis as a side effect. This form of hypophysitis is now seen with increased frequency but its pathogenesis remains unknown, in part due to the absence of pathological information. Read the full article here.



All Pathology News >>